Polycythemia Vera Treatment Market Size

Polycythemia Vera Treatment Market size is predicted to reach USD 45 billion by the end of 2036, growing at a CAGR of 7% during the forecast period i.e., 2024 – 2036. In the year 2023, the industry size of polycythemia vera treatment was USD 6 billion. The growth of this market can be ascribed to the development of new advanced treatments. Previously there was only one treatment for PV which was phlebotomy which consists of removing excess blood from the body. Recently, several new treatments have been developed such as Interferon alpha, JAK inhibitors, and myelosuppressive therapy. These treatments help patients manage lots of symptoms and enhance their quality of life.

In addition to this, increasing prevalence of polycythemia vera is anticipated to drive the polycythemia vera treatment market. Moreover, patients experience polycythemia vera symptoms over a long period of time. Before any visible symptoms appear, the disease is frequently discovered by chance during a routine exam that consists of a blood test. Early diagnosis increases the chance of rapid recovery in patients. As per data 1 in 3,300 people in the United States suffered from polycythemia vera.